[177Lu]Lu-Sn201
Solid Tumor, Recurrent Solid Tumor, Locally Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer, Unresectable Solid Tumor
Phase I/II
Recruiting
A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer
Dec 06, 2023
―
Sn132d
Endometriosis
Phase II
Completed
Efficacy of SN132D in Patients With Suspected Endometriosis
Dec 07, 2022
―
Sn132d
Breast Cancer, Pancreas Cancer
Phase I
Completed
A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer
Aug 27, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Spago Nanomedical AB (7UX) have in its pipeline
7UX is currently developing the following drugs: [177Lu]Lu-Sn201, Sn132d, Sn132d. These drug candidates are in various stages of clinical development as the company works toward FDA approval.